{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:30:16Z","timestamp":1790641816203,"version":"4.1.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>The majority of cells comprising the inflammatory infiltrates in kidney allografts undergoing acute and\/or chronic rejection are typically T cells and monocyte\/macrophages with B cells, plasma cells, and eosinophils accounting for &lt;5%. In a significant minority of biopsies, B lineage cells (B cells and\/or plasma cells) may be found more abundantly. Although plasma cell infiltrates tend to be more diffuse, B cells tend to aggregate into nodules that may mature into tertiary lymphoid organs. Given the ability to target B cells with anti-CD20 monoclonal antibodies and plasma cells with proteasome inhibitors and anti-CD38 monoclonal antibodies, it is increasingly important to determine the significance of such infiltrates. Both cell types are potential effectors of rejection, but both also have a tolerizing potential. B cell infiltrates have been associated with steroid resistance and reduced graft survival in some studies but not in others, and their presence should not prompt automatic depletional therapy. Plasma cell\u2013rich infiltrates tend to occur later, may be associated with cell-mediated and\/or antibody-mediated rejection, and portend an adverse outcome. Viral infection and malignancy must be ruled out. Randomized controlled trials are needed to determine the appropriateness of specific therapy when B cells and\/or plasma cells are found. No strong therapeutic recommendations can be made at this time.<\/jats:p>","DOI":"10.1097\/tp.0000000000003163","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T18:43:54Z","timestamp":1581101034000},"page":"2011-2023","source":"Crossref","is-referenced-by-count":18,"title":["The Implications of B-lineage Cells in Kidney Allografts"],"prefix":"10.1097","volume":"104","author":[{"given":"Edward J.","family":"Filippone","sequence":"first","affiliation":[{"name":"Division of Nephrology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA."},{"name":"Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Farber","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"24","key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJM197506122922402","article-title":"Identity and cytotoxic capacity of cells infiltrating renal allografts.","volume":"292","author":"Strom","year":"1975","journal-title":"N Engl J Med"},{"issue":"3","key":"R2-20231002","first-page":"272","article-title":"T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.","volume":"35","author":"Busch","year":"1976","journal-title":"Lab Invest"},{"issue":"2","key":"R3-20231002","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa035588","article-title":"Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.","volume":"349","author":"Sarwal","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"R4-20231002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ki.2008.249","article-title":"Characterization of intra-graft B cells during renal allograft rejection.","volume":"74","author":"Zarkhin","year":"2008","journal-title":"Kidney Int"},{"issue":"7","key":"R5-20231002","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/TP.0000000000000124","article-title":"Expansion and somatic hypermutation of B cell clones in rejected human kidney grafts.","volume":"98","author":"Ferdman","year":"2014","journal-title":"Transplantation"},{"issue":"7","key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1600-6143.2008.02232.x","article-title":"Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts.","volume":"8","author":"Einecke","year":"2008","journal-title":"Am J Transplant"},{"issue":"3","key":"R7-20231002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.ASN.0000113316.52371.2E","article-title":"Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.","volume":"15","author":"Kerjaschki","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"R8-20231002","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/j.1600-6143.2005.01009.x","article-title":"Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts.","volume":"5","author":"Hippen","year":"2005","journal-title":"Am J Transplant"},{"issue":"12","key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1097\/01.tp.0000250572.46679.45","article-title":"CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients.","volume":"82","author":"Tsai","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"R10-20231002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1399-3046.2008.00943.x","article-title":"Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss.","volume":"13","author":"Muorah","year":"2009","journal-title":"Pediatr Transplant"},{"issue":"12","key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/TP.0b013e3181dd35b8","article-title":"Clinical impacts of CD38+ B cells on acute cellular rejection with CD20+ B cells in renal allograft.","volume":"89","author":"Hwang","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"R12-20231002","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1681\/ASN.2005040412","article-title":"Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.","volume":"16","author":"Eikmans","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"R13-20231002","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.transproceed.2006.10.173","article-title":"The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft.","volume":"38","author":"Doria","year":"2006","journal-title":"Transplant Proc"},{"issue":"4","key":"R14-20231002","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1600-6143.2007.01737.x","article-title":"Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion.","volume":"7","author":"Kayler","year":"2007","journal-title":"Am J Transplant"},{"issue":"8","key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1600-6143.2007.01885.x","article-title":"CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival.","volume":"7","author":"Bagnasco","year":"2007","journal-title":"Am J Transplant"},{"issue":"6","key":"R16-20231002","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/TP.0b013e3181860a74","article-title":"B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.","volume":"86","author":"Scheepstra","year":"2008","journal-title":"Transplantation"},{"issue":"5","key":"R17-20231002","first-page":"405","article-title":"Expression patterns of B cells in acute kidney transplant rejection.","volume":"12","author":"Carpio","year":"2014","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"R18-20231002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1600-6143.2006.01638.x","article-title":"Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies.","volume":"7","author":"Stuht","year":"2007","journal-title":"Am J Transplant"},{"issue":"4","key":"R19-20231002","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/TXD.0000000000000659","article-title":"Absence of intragraft B cells in rejection biopsies after rituximab induction therapy: consequences for clinical outcome.","volume":"3","author":"van den Hoogen","year":"2017","journal-title":"Transplant Direct"},{"issue":"3","key":"R20-20231002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2215\/CJN.01741105","article-title":"Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (campath-1H).","volume":"1","author":"Gallon","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"R21-20231002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines.","volume":"15","author":"Shen","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"R22-20231002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.2011.317","article-title":"A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection.","volume":"81","author":"Thaunat","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"R23-20231002","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function.","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation.","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"issue":"7492","key":"R25-20231002","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2017.02.004","article-title":"Regulatory B cells: phenotype, function and role in transplantation.","volume":"41","author":"Wortel","year":"2017","journal-title":"Transpl Immunol"},{"issue":"1","key":"R27-20231002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.12800","article-title":"Regulatory B cells: development, phenotypes, functions, and role in transplantation.","volume":"292","author":"Alhabbab","year":"2019","journal-title":"Immunol Rev"},{"issue":"1","key":"R28-20231002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1681\/ASN.2008121268","article-title":"Molecular phenotypes of acute rejection predict kidney graft prognosis.","volume":"21","author":"Viklicky","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"R29-20231002","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ajt.13122","article-title":"Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study.","volume":"15","author":"Shabir","year":"2015","journal-title":"Am J Transplant"},{"issue":"3","key":"R30-20231002","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ki.2015.100","article-title":"B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.","volume":"88","author":"Shiu","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"R31-20231002","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int"},{"issue":"6","key":"R32-20231002","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.","volume":"120","author":"Sagoo","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"R33-20231002","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans.","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"issue":"23","key":"R34-20231002","doi-asserted-by":"crossref","first-page":"37935","DOI":"10.18632\/oncotarget.16229","article-title":"Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis.","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"R35-20231002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-0012.2004.00292.x","article-title":"Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.","volume":"19","author":"Alausa","year":"2005","journal-title":"Clin Transplant"},{"issue":"4","key":"R36-20231002","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1600-6143.2006.01246.x","article-title":"Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.","volume":"6","author":"Lehnhardt","year":"2006","journal-title":"Am J Transplant"},{"issue":"11","key":"R37-20231002","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/TP.0b013e3181735723","article-title":"B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.","volume":"85","author":"Thaunat","year":"2008","journal-title":"Transplantation"},{"issue":"1","key":"R38-20231002","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/TP.0000000000002992","article-title":"Anti-BAFF treatment interferes with humoral responses in a model of renal transplantation in rats.","volume":"104","author":"Steines","year":"2020","journal-title":"Transplantation"},{"issue":"10140","key":"R39-20231002","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/S0140-6736(18)30984-X","article-title":"Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial.","volume":"391","author":"Banham","year":"2018","journal-title":"Lancet"},{"issue":"25","key":"R40-20231002","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection.","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"R41-20231002","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/ki.2014.261","article-title":"A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.","volume":"87","author":"Jackson","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"R42-20231002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13052","article-title":"Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety.","volume":"15","author":"van den Hoogen","year":"2015","journal-title":"Am J Transplant"},{"issue":"10","key":"R43-20231002","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"issue":"8","key":"R44-20231002","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/art.22811","article-title":"Development of psoriasis after B cell depletion with rituximab.","volume":"56","author":"Dass","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"R45-20231002","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ibd.20215","article-title":"Exacerbation of ulcerative colitis after rituximab salvage therapy.","volume":"13","author":"Goetz","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"R46-20231002","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.13099","article-title":"Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection.","volume":"192","author":"de Leur","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"R47-20231002","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ajt.13645","article-title":"The role of lymphoid neogenesis in allografts.","volume":"16","author":"Hsiao","year":"2016","journal-title":"Am J Transplant"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2016.00646","article-title":"Lymphoid neogenesis and tertiary lymphoid organs in transplanted organs.","volume":"7","author":"Koenig","year":"2016","journal-title":"Front Immunol"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3389\/fimmu.2017.01639","article-title":"Spoiling for a fight: B lymphocytes as initiator and effector populations within tertiary lymphoid organs in autoimmunity and transplantation.","volume":"8","author":"Alsughayyir","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"R50-20231002","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-6143.2007.01756.x","article-title":"Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection.","volume":"7","author":"Nasr","year":"2007","journal-title":"Am J Transplant"},{"issue":"41","key":"R51-20231002","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.0507223102","article-title":"Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response.","volume":"102","author":"Thaunat","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"R52-20231002","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.0903589","article-title":"Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis.","volume":"185","author":"Thaunat","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"R53-20231002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/eji.201040759","article-title":"Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection.","volume":"41","author":"Brown","year":"2011","journal-title":"Eur J Immunol"},{"issue":"3","key":"R54-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.6002\/ect.2017.0261","article-title":"Characterizing the B-cell and humoral response in tertiary lymphoid organs in kidney allografts.","volume":"17","author":"Nowocin","year":"2019","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"R55-20231002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.kint.2019.07.027","article-title":"Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.","volume":"97","author":"Pedersen","year":"2020","journal-title":"Kidney Int"},{"issue":"4","key":"R56-20231002","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ajpath.2010.12.024","article-title":"Early acceptance of renal allografts in mice is dependent on foxp3(+) cells.","volume":"178","author":"Miyajima","year":"2011","journal-title":"Am J Pathol"},{"issue":"4","key":"R57-20231002","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/TP.0000000000001588","article-title":"Crosstalk between T and B cells in the germinal center after transplantation.","volume":"101","author":"Kwun","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"R58-20231002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/08820139.2015.1085394","article-title":"Characterisation of tertiary lymphoid organs in explanted rejected donor kidneys.","volume":"45","author":"Xu","year":"2016","journal-title":"Immunol Invest"},{"issue":"1","key":"R59-20231002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2006.01584.x","article-title":"Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections.","volume":"7","author":"Di Carlo","year":"2007","journal-title":"Am J Transplant"},{"issue":"3","key":"R60-20231002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5114\/pjp.2016.63772","article-title":"Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?","volume":"67","author":"Szymanska","year":"2016","journal-title":"Pol J Pathol"},{"issue":"3","key":"R61-20231002","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00007890-199902150-00007","article-title":"The significance of bronchus-associated lymphoid tissue in human lung transplantation: is there an association with acute and chronic rejection?","volume":"67","author":"Hasegawa","year":"1999","journal-title":"Transplantation"},{"issue":"1","key":"R62-20231002","first-page":"6","article-title":"Depletion of bronchus-associated lymphoid tissue associated with lung allograft rejection.","volume":"132","author":"Hruban","year":"1988","journal-title":"Am J Pathol"},{"issue":"5","key":"R63-20231002","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/ard.2008.089284","article-title":"Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.","volume":"68","author":"Ca\u00f1ete","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"R64-20231002","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/TP.0000000000001217","article-title":"T follicular helper cells in transplantation.","volume":"100","author":"Walters","year":"2016","journal-title":"Transplantation"},{"key":"R65-20231002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coi.2019.01.004","article-title":"B cells in the formation of tertiary lymphoid organs in autoimmunity, transplantation and tumorigenesis.","volume":"57","author":"Corsiero","year":"2019","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"R66-20231002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"R67-20231002","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/art.40479","article-title":"Brief report: a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis.","volume":"70","author":"Cheng","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"R68-20231002","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/rheumatology\/key182","article-title":"Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2.","volume":"57","author":"Genovese","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R69-20231002","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3389\/fimmu.2018.01707","article-title":"T follicular helper-like cells in inflamed non-lymphoid tissues.","volume":"9","author":"Hutloff","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"R70-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation.","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"R71-20231002","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1681\/ASN.2017060679","article-title":"Control of humoral response in renal transplantation by belatacept depends on a direct effect on B cells and impaired T follicular helper-B cell crosstalk.","volume":"29","author":"Leibler","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"R72-20231002","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1681\/ASN.2019030304","article-title":"Pretransplant desensitization with costimulation blockade and proteasome inhibitor reduces DSA and delays antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients.","volume":"30","author":"Ezekian","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R73-20231002","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fimmu.2017.00641","article-title":"Belatacept does not inhibit follicular T cell-dependent B-cell differentiation in kidney transplantation.","volume":"8","author":"de Graav","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"R74-20231002","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00432522","article-title":"The immunological significance of cellular infiltrates in chronic rejection of human kidney transplants.","volume":"368","author":"Schl\u00fcter","year":"1975","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"1","key":"R75-20231002","first-page":"37","article-title":"Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys.","volume":"9","author":"Busch","year":"1977","journal-title":"Transplant Proc"},{"issue":"1","key":"R76-20231002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00007890-198201000-00025","article-title":"Immunoglobulin-secreting cells recovered from rejected human renal allografts.","volume":"33","author":"Garovoy","year":"1982","journal-title":"Transplantation"},{"issue":"2\u20133","key":"R77-20231002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0344-0338(11)80768-5","article-title":"Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study.","volume":"187","author":"N\u00e1dasdy","year":"1991","journal-title":"Pathol Res Pract"},{"issue":"1 Pt 2","key":"R78-20231002","first-page":"897","article-title":"Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss.","volume":"25","author":"David-Neto","year":"1993","journal-title":"Transplant Proc"},{"issue":"6","key":"R79-20231002","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/00007890-199909270-00011","article-title":"Plasma cell-rich acute renal allograft rejection.","volume":"68","author":"Charney","year":"1999","journal-title":"Transplantation"},{"issue":"2","key":"R80-20231002","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/hupa.2001.21574","article-title":"The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.","volume":"32","author":"Meehan","year":"2001","journal-title":"Hum Pathol"},{"issue":"4","key":"R81-20231002","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/gfh027","article-title":"Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome.","volume":"19","author":"Desvaux","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"R82-20231002","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/01.tp.0000215014.40595.ab","article-title":"Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance.","volume":"81","author":"G\u00e4rtner","year":"2006","journal-title":"Transplantation"},{"issue":"8","key":"R83-20231002","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1440-1797.2011.01487.x","article-title":"Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia.","volume":"16","author":"Rogers","year":"2011","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"R84-20231002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4103\/0971-4065.98753","article-title":"Plasma cell-rich acute rejection of the renal allograft: a distinctive morphologic form of acute rejection?","volume":"22","author":"Gupta","year":"2012","journal-title":"Indian J Nephrol"},{"issue":"9","key":"R85-20231002","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/ctr.12589","article-title":"Plasma cell-rich acute rejections in living-related kidney transplantation: a clinicopathological study of 50 cases.","volume":"29","author":"Abbas","year":"2015","journal-title":"Clin Transplant"},{"issue":"3","key":"R86-20231002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/0971-4065.159300","article-title":"Expanding the antibody-mediated component of plasma cell-rich acute rejection: a case series.","volume":"26","author":"Uppin","year":"2016","journal-title":"Indian J Nephrol"},{"issue":"4","key":"R87-20231002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00467-016-3524-0","article-title":"Plasma-cell-rich infiltrates in paediatric renal transplant biopsies are associated with increased risk of renal allograft failure.","volume":"32","author":"Dufek","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"R88-20231002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/TP.0000000000002041","article-title":"Clinical and pathological features of plasma cell-rich acute rejection after kidney transplantation.","volume":"102","author":"Hasegawa","year":"2018","journal-title":"Transplantation"},{"key":"R89-20231002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nep.13273","article-title":"Clinicopathological and immunohistochemical analysis of plasma cell-rich rejection in renal transplantation: involvement of intratubular Th1\/Th2 balance in plasma cell enrichment.","volume":"23","author":"Nishimura","year":"2018","journal-title":"Nephrology (Carlton)"},{"key":"R90-20231002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nep.13277","article-title":"Clinicopathological features and outcomes of kidney allografts in plasma cell-rich acute rejection: a case series.","volume":"23","author":"Hamada","year":"2018","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"R91-20231002","doi-asserted-by":"crossref","first-page":"e13500","DOI":"10.1111\/petr.13500","article-title":"Allograft outcomes of treated children with kidney transplant who developed plasma cell-rich acute rejection (PCAR): a single center\u2019s experience.","volume":"23","author":"Alhamoud","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"3","key":"R92-20231002","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"issue":"7","key":"R93-20231002","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1681\/ASN.2018121254","article-title":"Daratumumab in sensitized kidney transplantation: potentials and limitations of experimental and clinical use.","volume":"30","author":"Kwun","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"R94-20231002","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.transproceed.2008.03.097","article-title":"A retrospective study of plasma cell infiltrates in explanted renal allografts.","volume":"40","author":"Xu","year":"2008","journal-title":"Transplant Proc"},{"issue":"2","key":"R95-20231002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/modpathol.3800033","article-title":"Acute rejection and graft survival in renal transplanted patients with viral diseases.","volume":"17","author":"Aiello","year":"2004","journal-title":"Mod Pathol"},{"issue":"4","key":"R96-20231002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-2277.2009.01001.x","article-title":"Plasma cell infiltrates in polyomavirus nephropathy.","volume":"23","author":"Kem\u00e9ny","year":"2010","journal-title":"Transpl Int"},{"issue":"3","key":"R97-20231002","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0272-6386(97)90295-X","article-title":"Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?","volume":"30","author":"Trpkov","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"R98-20231002","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0272-6386(96)90470-9","article-title":"Histopathology of renal posttransplant lymphoproliferation: comparison with rejection using the Banff schema.","volume":"28","author":"Randhawa","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"R99-20231002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000478-199605000-00003","article-title":"Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease.","volume":"20","author":"Randhawa","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"R100-20231002","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/TP.0b013e318242162d","article-title":"Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.","volume":"93","author":"Zimmermann","year":"2012","journal-title":"Transplantation"},{"issue":"7","key":"R101-20231002","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3324\/haematol.2010.039214","article-title":"Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases.","volume":"96","author":"Trappe","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"R102-20231002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/tri.12091","article-title":"Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.","volume":"26","author":"Karuturi","year":"2013","journal-title":"Transpl Int"},{"issue":"3","key":"R103-20231002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ajt.14603","article-title":"Comprehensive review of post-organ transplant hematologic cancers.","volume":"18","author":"Dharnidharka","year":"2018","journal-title":"Am J Transplant"},{"issue":"1","key":"R104-20231002","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41467-019-09930-3","article-title":"Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.","volume":"10","author":"Pineda","year":"2019","journal-title":"Nat Commun"},{"issue":"14","key":"R105-20231002","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1073\/pnas.1101148108","article-title":"Ectopic B-cell clusters that infiltrate transplanted human kidneys are clonal.","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R106-20231002","first-page":"123","article-title":"Latent membrane protein expression in post-transplant lymphoproliferative disease.","volume":"3","author":"Dhir","year":"1995","journal-title":"Appl Immunohistochem"},{"issue":"1","key":"R107-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.6002\/ect.2017.0154","article-title":"Management of plasma cell-rich acute rejection in living-related kidney transplant: role of proteasome inhibitor.","volume":"17","author":"Abbas","year":"2019","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"R108-20231002","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.transproceed.2019.02.038","article-title":"Bortezomib eliminates plasma cells from a renal graft in plasma cell-rich acute rejection.","volume":"51","author":"Tasaki","year":"2019","journal-title":"Transplant Proc"},{"key":"R109-20231002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.coi.2018.09.012","article-title":"Natural regulatory plasma cells.","volume":"55","author":"Fillatreau","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"R110-20231002","article-title":"Heterogeneous subsets of B-lineage regulatory cells (Breg cells).","author":"Baba","year":"2019","journal-title":"Int Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:48:24Z","timestamp":1696225704000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003163","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}